Abstract
Nocturia is a widespread condition that can negatively impact quality of sleep and overall health. This condition is multifactorial in nature and is best approached through the analysis of frequency volume charts. Through these charts, clinicians may classify each individual case of nocturia into one of four distinct categories: global polyuria, nocturnal polyuria, reduced bladder capacity, and mixed. Treatments should then be tailored to each individual based upon the category of their nocturia. In some cases, appropriate therapy will consist of behavioral modification techniques or addressing underlying systemic diseases. In other cases, medical therapy may be necessary, but, to date, medications have shown limited efficacy at treating nocturia.
Highlights
Nocturia is a prevalent and highly bothersome lower urinary tract symptom (LUTS)
This study demonstrated that nocturia is associated with impaired health-related quality of life (HRQoL) as measured by the generic 15D HRQoL instrument[4]
The frequency volume chart (FVC) is a key diagnostic tool because it allows clinicians to classify each individual case of nocturia into one of four basic categories: global polyuria, nocturnal polyuria, reduced bladder capacity, and mixed
Summary
Nocturia is a prevalent and highly bothersome lower urinary tract symptom (LUTS). In 2002, the International Continence Society (ICS) defined nocturia as “the complaint that the individual has to wake at night one or more times to void”[1]. Management strategies Behavioral modification techniques are appropriate first-line treatment for patients with nocturia, regardless of the etiology These include modifying global and evening fluid intake, restricting the consumption of foods that promote diuresis, and improving patient understanding of the physiology of storing and voiding urine[26]. In a meta-analysis of five studies, patients with OSA and nocturia had reductions in the frequency of nocturia and night-time urine volume after treatment with continuous positive airway pressure (CPAP)[29]. A prospective randomized study of 66 men with BPH and nocturia showed that transurethral resection of the prostate (TURP) reduced the mean number of nightly voids by one at 1-year follow-up, outperforming tamsulosin by 0.34 awakenings per night[37]. The clinical significance of OAB medications is likely limited for treating nocturia
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
